CADL
Candel Therapeutics, Inc.
Biological Products, (No Diagnostic Substances)Nasdaq<br>Emerging growth company
Total Trades
34
Buys
7
Sells
23
Largest Trade
$1M+
Insiders
10
Institutional Funds
62
Inst. Value
$1M+
Activist Filings
11
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Manning Paul B | Director | BUY | $1M+ | 550K | $5.45 | Feb 27, 2026 |
| Nichols William Garrett | Chief Medical Offi… | SELL | $1K–$15K | 937 | $6.98 | Jul 30, 2025 |
| Nichols William Garrett | Chief Medical Offi… | EXERCISE | $1K–$15K | 937 | $1.29 | Jul 30, 2025 |
| Nichols William Garrett | Chief Medical Offi… | EXERCISE | $1K–$15K | 781 | $1.29 | Jul 2, 2025 |
| Nichols William Garrett | Chief Medical Offi… | SELL | $1K–$15K | 781 | $5.04 | Jul 2, 2025 |
| Nichols William Garrett | Chief Medical Offi… | EXERCISE | $15K–$50K | 18K | $1.90 | Mar 20, 2025 |
| Nichols William Garrett | Chief Medical Offi… | SELL | $100K–$500K | 45K | $8.76 | Mar 20, 2025 |
| Barone Francesca | Chief Scientific O… | EXERCISE | $15K–$50K | 18K | $1.55 | Mar 20, 2025 |
| Barone Francesca | Chief Scientific O… | SELL | $100K–$500K | 32K | $8.76 | Mar 20, 2025 |
| Tak Paul Peter | CEO | SELL | $100K–$500K | 26K | $8.77 | Mar 20, 2025 |
| Tyagarajan Seshu | CTO | SELL | $100K–$500K | 31K | $8.82 | Mar 19, 2025 |
| Schoch Charles | See Remarks | SELL | $15K–$50K | 5K | $8.83 | Mar 19, 2025 |
| Barone Francesca | Chief Scientific O… | SELL | $50K–$100K | 14K | $7.22 | Jan 17, 2025 |
| Tyagarajan Seshu | CTO | SELL | $100K–$500K | 14K | $7.22 | Jan 17, 2025 |
| Schoch Charles | See Remarks | SELL | $50K–$100K | 10K | $7.22 | Jan 17, 2025 |
| Tak Paul Peter | CEO | SELL | $100K–$500K | 22K | $7.22 | Jan 17, 2025 |
| Nichols William Garrett | Chief Medical Offi… | SELL | $50K–$100K | 10K | $7.22 | Jan 17, 2025 |
| Barone Francesca | Chief Scientific O… | SELL | $100K–$500K | 14K | $8.22 | Jan 10, 2025 |
| Schoch Charles | See Remarks | SELL | $50K–$100K | 10K | $8.22 | Jan 10, 2025 |
| Tak Paul Peter | CEO | SELL | $100K–$500K | 21K | $8.22 | Jan 10, 2025 |
| Tyagarajan Seshu | CTO | SELL | $100K–$500K | 15K | $8.22 | Jan 10, 2025 |
| Nichols William Garrett | Chief Medical Offi… | SELL | $50K–$100K | 11K | $8.22 | Jan 10, 2025 |
| Tyagarajan Seshu | CTO | SELL | $50K–$100K | 20K | $4.56 | Dec 3, 2024 |
| Tak Paul Peter | CEO | SELL | $100K–$500K | 49K | $4.56 | Dec 3, 2024 |
| Nichols William Garrett | Chief Medical Offi… | SELL | $50K–$100K | 14K | $4.56 | Dec 3, 2024 |
| Barone Francesca | Chief Scientific O… | SELL | $100K–$500K | 22K | $4.56 | Dec 3, 2024 |
| Aguilar-Cordova Estuardo | 10% Owner | SELL | $100K–$500K | 40K | $6.03 | Oct 15, 2024 |
| Aguilar-Cordova Estuardo | 10% Owner | SELL | $100K–$500K | 35K | $6.93 | Oct 3, 2024 |
| Barone Francesca | Chief Scientific O… | BUY | $1K–$15K | 1K | $1.61 | Dec 12, 2022 |
| PAPA JOSEPH C | Director | BUY | $50K–$100K | 38K | $1.92 | Dec 12, 2022 |
| Martell Christopher | Director | BUY | $50K–$100K | 27K | $1.89 | Dec 12, 2022 |
| Tak Paul Peter | CEO | BUY | $15K–$50K | 16K | $1.88 | Dec 12, 2022 |
| Tyagarajan Seshu | CTO | BUY | $15K–$50K | 13K | $1.88 | Dec 12, 2022 |
| Amello Jason | CFO | BUY | $1K–$15K | 6K | $1.80 | Dec 12, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 62 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Portolan Capital Management, LLC | 1.7M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 852K | $1M+ | SH |
| STATE STREET CORP | 792K | $1M+ | SH |
| Halter Ferguson Financial Inc. | 748K | $1M+ | SH |
| Sands Capital Alternatives, LLC | 406K | $1M+ | SH |
| Tanager Wealth Management LLP | 198K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 121K | $500K+ | SH |
| UBS Group AG | 102K | $500K+ | SH |
| Nuveen, LLC | 92K | $500K+ | SH |
| COMMONWEALTH EQUITY SERVICES, LLC | 82K | $100K–$500K | SH |
| Focus Partners Wealth | 82K | $100K–$500K | SH |
| MORGAN STANLEY | 74K | $100K–$500K | SH |
| BARCLAYS PLC | 69K | $100K–$500K | SH |
| ALLIANCEBERNSTEIN L.P. | 69K | $100K–$500K | SH |
| Birchview Capital, LP | 60K | $100K–$500K | SH |
| HB Wealth Management, LLC | 58K | $100K–$500K | SH |
| Lido Advisors, LLC | 60K | $100K–$500K | SH |
| RHUMBLINE ADVISERS | 51K | $100K–$500K | SH |
| WELLS FARGO & COMPANY/MN | 48K | $100K–$500K | SH |
| ALPS ADVISORS INC | 45K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Jan 21, 2026
5.2%
2.9M shares
SC 13G · Jun 30, 2025
2.2%
1.1M shares
SC 13G/A · May 15, 2025
5.0%
2.5M shares
SC 13G/A · Feb 14, 2025
0.0%
0 shares
SC 13G · Feb 14, 2025
6.8%
3.0M shares
SC 13G/A · Feb 7, 2025
0.0%
0 shares
SC 13G/A · Feb 7, 2025
15.0%
6.3M shares
SC 13G · Feb 7, 2025
9.3%
3.9M shares
SC 13G · Dec 17, 2024
5.6%
2.4M shares
SC 13G · Feb 14, 2022
5.9%
1.7M shares
SC 13D · Feb 14, 2022
13.6%
4.1M shares